Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Researchers
>
Publications and Presentations
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
Publications and Presentations
21-Sep-2024
EVT801 Presentation at the 15th Biennial Ovarian Cancer Research Symposium
11-Apr-2024
EVT801 Phase 1 clinical trial poster presentation at AACR 2024
11-Apr-2024
EVT801 Phase 1 biomarker analysis poster presentation at AACR 2024
24-Oct-2023
EVT801 Phase 1 clinical trial poster presentation from ESMO 2023
25-May-2023
EVT801 Phase I Clinical Trial poster presented at AACR23
17-May-2023
Cancer Research publishes pre-clinical findings on DIPG/DMG trial
25-Oct-2022
Poster at Int. Congress of the Society for Melanoma Research
3-Jun-2022
Paxalisib phase II study poster presented as ASCO 2022
4-Jun-2021
Kazia Therapeutics to present at LD Micro Invitational XI
21-Nov-2020
Paxalisib poster presented at SNO (virtual meeting)
22-Jun-2020
Paxalisib poster presented at AACR (virtual meeting)
1-Jun-2020
Paxalisib poster presented at ASCO (virtual meeting)
Click here for archives
